hydroxychloroquine has been researched along with pyridostigmine bromide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Elahi, B; Laughlin, RS; Liewluck, T; Litchy, WJ; Milone, M | 1 |
Koc, G; Odabasi, Z; Tan, E | 1 |
2 other study(ies) available for hydroxychloroquine and pyridostigmine bromide
Article | Year |
---|---|
Neuromuscular transmission defects in myopathies: Rare but worth searching for.
Topics: Cholinesterase Inhibitors; Cohort Studies; Electrodiagnosis; Electromyography; Female; Genetic Diseases, X-Linked; Humans; Hydroxychloroquine; Immunotherapy; Lysosomal Storage Diseases; Male; Motor Neurons; Muscle, Skeletal; Muscular Diseases; Myopathies, Structural, Congenital; Pyridostigmine Bromide; Synaptic Transmission | 2019 |
Myasthenic Syndrome Caused by Hydroxychloroquine Used for COVID-19 Prophylaxis.
Topics: Antimalarials; Betacoronavirus; Cholinesterase Inhibitors; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Male; Middle Aged; Myasthenia Gravis; Pandemics; Pneumonia, Viral; Pyridostigmine Bromide; SARS-CoV-2 | 2020 |